Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480542 · ClinicalTrials.gov registry record
Central Venous Access Study
A clinical trial of Central Line Catheters, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 217
- Enrollment target
- 1
- Study location
NCT03480542: Completed study of Central Line Catheters, sponsored by Hackensack Meridian Health.
NCT03480542 is a study of Central Line Catheters that has completed, run by Hackensack Meridian Health. The registered enrollment target is 217 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03480542, a study of Central Line Catheters, has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and procedures for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD catheters by way of a structured retrospective review of the Electronic Medical Record (EMR) system.
Primary Outcome
Number of medical records with documented mechanical/technical, thrombotic, and other adverse outcomes associated with use of CVCs, PICCs, and Hemodialysis (HD) catheters.
Conditions Studied
Study Locations (1)
New Jersey
- Hackensack University Medical Center - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2022-04-07 |
What the finished NCT03480542 record still lists
NCT03480542 is an observational study that tracks outcomes without assigning an intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Central Line Catheters appearing as the primary indexed condition, and to 0 interventions.
NCT03480542 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03480542 about?
NCT03480542 is a clinical study titled "Central Venous Access Study". The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and procedures for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodial...
What is the current status of trial NCT03480542?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2017-04-11. Estimated completion is 2022-04-07.
What conditions does trial NCT03480542 study?
This clinical trial studies the following conditions: Central Line Catheters.
Who is sponsoring clinical trial NCT03480542?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03480542 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI